Browse our comprehensive collection of market intelligence reports.
The clinical chemistry analyzer market is projected to grow at a 4.01% CAGR, increasing from USD 15.346 billion in 2025 to USD 18.680 billion by 2030. A clinical chemistry analyzer or biochemistry analyzer is a medical device used in clinical laboratories to perform various biochemical tests on patient samples, such as blood, urine, or other body fluids.
The electric actuator market is estimated to grow at a steady rate during the forecast period. An electric actuator is a mechanical device that harnesses the power of an electric motor to produce controlled linear or rotary motion. This mechanism is specifically designed to generate force and induce movement in a load or perform tasks that require the application of force, such as clamping. By converting electrical energy into kinetic energy, electric actuators enable precise and controlled m
The drum brakes market, growing at a 4.59% CAGR, is projected to achieve USD 7.122 billion by 2030 from USD 5.691 billion in 2025. A drum brake is a type of brake that utilizes brake shoes or pads to create friction against a rotating brake drum for stopping or slowing down a vehicle.
The vitamin D testing market, with a 9.00% CAGR, is expected to grow to USD 1,459.289 million in 2030 from USD 948.438 million in 2025. Vitamin D maintains healthy bones and teeth, prevents type I diabetes and cancer, and improves intestinal absorption of calcium, magnesium, and phosphate.
The continuous use of opioids that results in clinically significant distress or impairment is referred to as opioid use disorder. Opioid use disorder is characterized by an overwhelming need to use opioids. Hence, dependency and addiction are features of the most severe kind of opioid use disorder. Opioid use disorder includes serious side effects that might result in impairment, relapses, and even death.
The joint spacer market is expected to grow at a 6.22% CAGR, achieving USD 2.052 billion by 2030 from USD 1.518 billion in 2025. The joint-spacer market is anticipated to rise at a steady pace during the projected period. Joint spacer systems are articulating spacers or readymade spacers that come in a variety of sizes and are loaded with antibiotics.
The heparin market, with a 5.15% CAGR, is projected to increase from USD 6.598 billion in 2025 to USD 8.481 billion in 2030. The heparin market is anticipated to grow at a steady pace throughout the forecast period. Heparin prevents blood clotting in the body and acts as an anticoagulant used in medicines, blood specimens, and kidney dialysis machines.
The airway management devices market is forecasted to rise at a 6.10% CAGR, reaching USD 4.081 billion by 2030 from USD 3.035 billion in 2025. Airway management is an essential activity in an emergency, and a lack of airway management may cause reduced oxygen levels and life-threatening conditions. </span
The turf protection market, growing at a 4.68% CAGR, is expected to grow to USD 9.082 billion in 2030 from USD 7.225 billion in 2025. Turf protection is required as turf grasses prevent soil erosion, improve flood control, produce oxygen, and temperature modification.
The orthobiologics market is projected to expand at a 4.64% CAGR, attaining USD 8.549 billion by 2030 from USD 6.816 billion in 2025. Orthobiologics are majorly used to treat acute and chronic conditions related to muscles, bones, joints, and soft tissues. The growing demand for advanced treatment coupled with the improved living standard and increased disposable income are major growth drivers of the orthobiologics market.
The latex agglutination test kits market, with a 4.59% CAGR, is anticipated to reach USD 731.218 million in 2030 from USD 584.260 million in 2025. Latex agglutination is used to detect antibodies and microorganisms. The diversified application of latex tests in antigens detection coupled with rising cases of infections due to changing lifestyles is expected to propel the latex agglutination market size.&nbs
Huntington’s Disease Treatment Market is expected to grow at a 15.15% CAGR, achieving USD 1.892 billion by 2030 from USD 0.935 billion in 2025. Huntington’s disease treatment market is anticipated to grow at a steady pace. Due to the organism's aberrant response against its own tissue, autoimmune disease results in the breakdown of normal immunological homeostasis.